DE60221724D1 - Anti-HIV Substanz - Google Patents

Anti-HIV Substanz

Info

Publication number
DE60221724D1
DE60221724D1 DE60221724T DE60221724T DE60221724D1 DE 60221724 D1 DE60221724 D1 DE 60221724D1 DE 60221724 T DE60221724 T DE 60221724T DE 60221724 T DE60221724 T DE 60221724T DE 60221724 D1 DE60221724 D1 DE 60221724D1
Authority
DE
Germany
Prior art keywords
hiv substance
hiv
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221724T
Other languages
English (en)
Other versions
DE60221724T2 (de
Inventor
Manabu Wada
Naokou Wada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JCR Pharmaceuticals Co Ltd
Original Assignee
JCR Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JCR Pharmaceuticals Co Ltd filed Critical JCR Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of DE60221724D1 publication Critical patent/DE60221724D1/de
Publication of DE60221724T2 publication Critical patent/DE60221724T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60221724T 2001-02-20 2002-02-15 Anti-HIV Substanz Expired - Lifetime DE60221724T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001042655 2001-02-20
JP2001042655 2001-02-20
JP2001184284A JP4034530B2 (ja) 2001-02-20 2001-06-19 抗ｈｉｖ剤
JP2001184284 2001-06-19

Publications (2)

Publication Number Publication Date
DE60221724D1 true DE60221724D1 (de) 2007-09-27
DE60221724T2 DE60221724T2 (de) 2008-06-05

Family

ID=26609669

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221724T Expired - Lifetime DE60221724T2 (de) 2001-02-20 2002-02-15 Anti-HIV Substanz

Country Status (8)

Country Link
US (3) US20020193304A1 (de)
EP (1) EP1232755B1 (de)
JP (1) JP4034530B2 (de)
KR (1) KR100858862B1 (de)
CN (1) CN100479857C (de)
AU (1) AU784414B2 (de)
BR (1) BR0200495A (de)
DE (1) DE60221724T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540529C (en) * 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
CN101094651B (zh) * 2004-12-30 2011-03-09 多贝尔有限公司 含有胶原凝集素家族蛋白质或者其变体的喷雾干燥的组合物和其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248715B1 (en) * 1993-06-01 2001-06-19 Chiron Corporation Method of treating a urokinase-type plasminogen activator-mediated disorder
US5532132A (en) * 1993-09-28 1996-07-02 President And Fellows Of Harvard University Method for regulating formation of a complex of plasminogen activator, its receptor and inhibitor
WO1996013160A1 (en) * 1994-11-01 1996-05-09 New England Deaconess Hospital Use of urokinase-type plasminogen activators to inhibit hiv infectivity
US5874254A (en) * 1996-03-29 1999-02-23 Director-General Of Agency Of Industrial Science And Technology FGF-5 analogous protein, and pharmaceutical composition containing the same
IL132323A0 (en) * 1997-04-28 2001-03-19 Rhone Poulenc Rorer Sa Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
AU2001281747A1 (en) * 2000-08-02 2002-02-13 H:S Hvidovre Hospital Composition and method for the treatment or prevention of hiv infection

Also Published As

Publication number Publication date
CN1371747A (zh) 2002-10-02
US20020193304A1 (en) 2002-12-19
DE60221724T2 (de) 2008-06-05
AU1558902A (en) 2002-08-22
AU784414B2 (en) 2006-03-30
KR100858862B1 (ko) 2008-09-17
US20100135989A1 (en) 2010-06-03
JP4034530B2 (ja) 2008-01-16
BR0200495A (pt) 2002-12-31
EP1232755A3 (de) 2002-09-18
CN100479857C (zh) 2009-04-22
EP1232755B1 (de) 2007-08-15
JP2002356442A (ja) 2002-12-13
US20070190077A1 (en) 2007-08-16
EP1232755A2 (de) 2002-08-21
KR20020068299A (ko) 2002-08-27

Similar Documents

Publication Publication Date Title
DE50204184D1 (de) Espressobrüheinrichtung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE50208022D1 (de) Wischblatt
DE50206021D1 (de) Schlauchklemme
DE50103741D1 (de) Welle-Nabe-Verbindung
DE50204386D1 (de) Kreuztransducer
DE50209238D1 (de) Kugelgelenk
ATE335486T1 (de) Hydrazono-malonitrile
DE1319930T1 (de) Coriolismassendurchflussmesser
DE50204551D1 (de) Kugelgelenk
DE50208372D1 (de) Schrankaufhängevorrichtung
DE50204794D1 (de) Kugelgelenk
DE50203984D1 (de) Kugelgelenk
DE50203412D1 (de) Schwenkkolbenverdränger
ATE355059T1 (de) Isoxazolopyridinone
DE50208029D1 (de) Kugelgelenk
DE50201862D1 (de) Messwandler
DE50203093D1 (de) Losradlager
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
DE50209293D1 (de) Amidpolymermasse
DE50207815D1 (de) Kugelgelenk
DE50202088D1 (de) Garmodulsystem
DE60221724D1 (de) Anti-HIV Substanz
DE60229395D1 (de) Altung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition